Analytical Data
-
基因名
DDTL
- Application
-
别名
DDTL；D-dopachrome decarboxylase-like Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A6NHG4
-
表达区间
1-134aa
-
氨基酸序列
MPFLELDTNLPANRVPAGLEKRLCAAAASILGKPADRVNVTVRPGLAMALSGSTEPCAQLSISSIGVVGTAEDNRSHSAHFFEFLTKELALGQDRFPTVLSTSPAAHGGPRCPGEIIEGKKSCLNEEALFIYFI
-
分子量
21.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DDTL (Double Domain Toxin-Like) recombinant proteins have garnered significant attention in the field of biotechnology and therapeutic development due to their unique structural and functional properties. Originally derived from bacterial toxins, the DDTL family exhibits a dual-domain architecture, which allows for enhanced specificity and potency in various biological applications. Research into DDTL recombinant proteins focuses on their potential uses in targeted therapies, particularly in cancer treatment and antimicrobial applications, where their ability to selectively target and eliminate diseased cells or pathogenic organisms is crucial. Additionally, the modular nature of DDTL proteins enables the incorporation of various functional moieties, facilitating the design of novel therapeutic agents with improved efficacy and reduced side effects. Advances in genetic engineering and protein expression systems have further propelled the study of DDTL proteins, allowing for the efficient production and characterization of these promising molecular entities. Overall, ongoing research aims to elucidate the mechanisms of action, optimize production processes, and explore the therapeutic potential of DDTL recombinants in addressing pressing medical challenges.
